title: The optimum time for drug licensing.
authors.affiliation: McKinsey & Company, San Francisco, California 94104, USA. james_kalamas@mckinsey.com
authors.forename: James
authors.initials: J
authors.lastname: Kalamas
authors.forename: Gary
authors.initials: G
authors.lastname: Pinkus
mesh_terms: D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence* / Q000379:methods; D002986:Clinical Trials as Topic / Q000191:economics / Q000331:legislation & jurisprudence* / Q000379:methods; D004335:Drug and Narcotic Control / Q000191:economics / Q000331:legislation & jurisprudence* / Q000379:methods; D006801:Humans; D013678:Technology, Pharmaceutical / Q000191:economics / Q000331:legislation & jurisprudence* / Q000379:methods; D013997:Time Factors